Article Details

Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd (GLMD) to Post -$0.12 EPS

Retrieved on: 2019-01-27 08:22:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd (GLMD) to Post -$0.12 EPS. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC lifted its holdings in shares of Galmed Pharmaceuticals by 1,768.2% in the second quarter. <b>Millennium Management</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo